USE OF HIGH DOSE CIS‐DICHLORODIAMMINE PLATINUM (II) (NSC—119875)† FOLLOWING FAILURE ON PREVIOUS CHEMOTHERAPY FOR ADVANCED CARCINOMA OF THE OVARY
Data up to Jan 2025
Total Citations Per Year
Abstract
References (9)
Second trial drugs in ovarian cancer
1977 • 88 citations
Hexamethylmelamine.An evaluation of its role in the therapy of cancer
1976 • 85 citations
Combination chemotherapy with adriamycin andcis-diamminedichloroplatinum in patients with neoplastic diseases
1976 • 67 citations
Mitigation of amphotericin B nephrotoxicity by mannitol.
1975 • 65 citations
Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapy.
1978 • 54 citations
cis-Platinum (II) Diamminedichloride
1974 • 43 citations
RANDOMISED TRIAL COMPARING LOW-DOSE CISPLATIN AND CHLORAMBUCIL WITH LOW-DOSE CISPLATIN, CHLORAMBUCIL, AND DOXORUBICIN IN ADVANCED OVARIAN CARCINOMA
1981 • 35 citations
Combination chemotherapy for alkylator-resistant ovarian carcinoma: a preliminary report of a Southwest Oncology Group trial.
1979 • 18 citations
Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.
1975 • 15 citations
Cited By (0)
No citing papers found in database